Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $100
ديكسكوم
DexCom, Inc. DXCM | 0.00 |
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:
DXCM) with a Buy and raises the price target from $95 to $100.
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $100
DexCom, Inc. DXCM | 0.00 |